Table 1:

Demographic and clinical characteristics of DDLT recipients with and without KidneyMELD at LT ≥50% between 2005-2017 (N=34,920)

	KidneyMELD at LT <50% (N=33,499)	KidneyMELD at LT ≥50% (N=1,421)	p-value
Male gender, %	65.9	66.0	0.9
Age at LT, median (IQR)	55 (48-61)	58 (53-63)	<0.001
Liver disease, %			<0.001
HCV	32.1	31.0
Alcohol	24.7	27.4
NASH	21.0	28.7
AI disease*	14.2	6.9
HBV	2.4	2.0
Other	5.8	4.0
MELD-Na at LT, median (IQR)	27 (21-34)	27 (20-31)	<0.001
Albumin at LT, median (IQR)	2.9 (2.4-3.4)	3.1 (2.7-3.6)	<0.001
Diabetes, %	23.0	39.4	<0.001
Ascites, %			<0.001
None	11.7	7.5
Mild	48.5	40.9
Moderate	39.9	51.7
Location prior to LT, %			<0.001
Home	58.9	52.8
Inpatient ward	26.2	29.6
Inpatient intensive care	15.0	17.7
Dialysis at LT, %	11.4	41.5	<0.001
Waiting time, median (IQR)	40 (11-156)	43 (10-163)	0.2
Donor age, median (IQR)	43 (27-55)	45 (28-57)	<0.001
DCDD organ, %	5.6%	6.1%	0.4

Abbreviations: AI – auto-immune; DCDD – donation after circulatory determination of death; DDLT – deceased donor liver transplantation; HBV – hepatitis B virus; HCV – hepatitis C virus; IQR – interquartile range; KidneyMELD – proportion of MELD-Na score attributable to creatinine; LT – liver transplantation; MELD-Na – Model for End-stage Liver Disease Sodium score; NASH – non-alcoholic steatohepatitis

^*Includes: auto-immune hepatitis, primary sclerosing cholangitis and primary biliary cholangitis